01.06.2016 Views

Sequencing

SFAF2016%20Meeting%20Guide%20Final%203

SFAF2016%20Meeting%20Guide%20Final%203

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

11th Annual <strong>Sequencing</strong>, Finishing, and Analysis in the Future Meeting<br />

ADVANCING MOLECULAR DIAGNOSTICS IN SUDDEN<br />

UNEXPLAINED DEATH A NEW YORK CITY<br />

EXPERIENCE<br />

Thursday, 2nd June 13:40 La Fonda Ballroom Talk (OS‐6.02)<br />

Yingying Tang<br />

New York City Office of Chief Medical Examiner (OCME)<br />

Sudden Unexplained Death (SUD) in previously healthy individuals is a vexing challenge facing forensic<br />

pathologists and a critical issue in public health today. SUD is a diagnostic exclusion which is defined<br />

as an undetermined cause of natural death after scene investigations, autopsy, and the review of past<br />

medical records. SUD is a critical issue that is not routinely investigated at molecular level. Powered<br />

with next‐generation sequencing technology, OCME evaluated the utility of molecular testing of a large<br />

number of genes in a well‐characterized and demographically diverse SUD cohort. I will present the<br />

results from that study to demonstrate the effectiveness and feasibility of molecular autopsy in a<br />

medical examiner setting. Furthermore, I will highlight the importance of family studies in clinical<br />

evaluation of high risk family members and function studies in enhancing our understanding of<br />

variants of uncertain significance, both type of studies are conducted through multi‐institutional<br />

and multi‐disciplinary collaborations. The feasibility and utility of broad molecular autopsy provides<br />

the first needed step in personalized diagnostics and precision preventive medicine for families of<br />

victims of SUD.<br />

111

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!